Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, reported its financial results for the second quarter of 2025. The company generated $7.4 million in total revenue, representing an 11% decline compared to the same period last year. This decline was anticipated and attributed to lower console sales achieved through a smaller and more cost-effective sales team. The company's gross margin increased to 41% for this quarter, up 320 basis points from the previous year. Sonendo reported a $3.6 million reduction in loss from continuing operations, totaling $3.9 million for the second quarter of 2025. This improvement was driven by focused operational efficiencies, leading to a 47% year-over-year improvement in Adjusted EBITDA loss, which stood at $3.0 million. Additionally, Sonendo significantly reduced its free cash flow burn to $2.6 million, a 61% decrease compared to the prior year period. As of June 30, 2025, the company held $9.3 million in cash, cash equivalents, and short-term investments, with $14.2 million of principal outstanding under its credit facility. For the full year of 2025, Sonendo reaffirmed its financial guidance, projecting revenue between $31 million and $32 million, with a GAAP gross margin of 44% to 46%. The company also anticipates an Adjusted EBITDA loss ranging from $11 million to $14 million, and free cash flow between negative $12 million and negative $15 million.